Medikamentenvergleiche
Miglitol vs. Vildagliptin
Miglitol (Alpha-Glucosidase-Inhibitor) verlangsamt die Kohlenhydratresorption; Vildagliptin (DPP-4-Inhibitor) steigert Insulin. Beide oral bei Typ-2-Diabetes.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
Patients with type 2 diabetes not responding adequately to metformin or sulfonylureas may require comparison of miglitol and vildagliptin.
Fazit
Miglitol and Vildagliptin are both viable oral antidiabetic medications, but the optimal choice varies based on patient-specific factors including mechanism of action and comorbidities.
Alle Medikamentenvergleiche